MLXIPL and hepatocellular carcinoma: Consistent with previous studies where the incidence of HCC development in HFD mice was only 2.5% [27], our study revealed an HCC frequency of around 1.5% in WT and 0.37% in L-ChREBP-KO HFD mice (Supplementary Table S5).